These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23510057)

  • 21. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.
    Home PD; Lindholm A; Riis A;
    Diabet Med; 2000 Nov; 17(11):762-70. PubMed ID: 11131100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structured type 1 diabetes education delivered in routine care in Australia reduces diabetes-related emergencies and severe diabetes-related distress: The OzDAFNE program.
    Speight J; Holmes-Truscott E; Harvey DM; Hendrieckx C; Hagger VL; Harris SE; Knight BA; McIntyre HD
    Diabetes Res Clin Pract; 2016 Feb; 112():65-72. PubMed ID: 26688058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
    Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
    Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of functional insulin therapy on glycaemic parameters in children with diabetes mellitus type 1.
    Štimjanin-Koldžo D; Alajbegović S; Štimjanin E; Mehinagić J
    Med Glas (Zenica); 2017 Aug; 14(2):164-168. PubMed ID: 28698534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland.
    McKnight JA; Ochs A; Mair C; McKnight O; Wright R; Gibb FW; Cunningham SG; Strachan M; Ritchie S; McGurnaghan SJ; Colhoun HM
    Diabet Med; 2020 Jun; 37(6):1016-1022. PubMed ID: 31872473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis.
    Dovc K; Telic SS; Lusa L; Bratanic N; Zerjav-Tansek M; Kotnik P; Stefanija MA; Battelino T; Bratina N
    Diabetes Technol Ther; 2014 Jan; 16(1):33-40. PubMed ID: 24131373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
    Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
    Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial.
    Davies MJ; Gross JL; Ono Y; Sasaki T; Bantwal G; Gall MA; Niemeyer M; Seino H;
    Diabetes Obes Metab; 2014 Oct; 16(10):922-30. PubMed ID: 24702700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)].
    Olsovský J; Beránek M
    Vnitr Lek; 2007 Jun; 53(6):637-45. PubMed ID: 17702123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries.
    Khunti K; Caputo S; Damci T; Dzida GJ; Ji Q; Kaiser M; Karnieli E; Liebl A; Ligthelm RJ; Nazeri A; Orozco-Beltran D; Pan C; Ross SA; Svendsen AL; Vora J; Yale JF; Meneghini LF;
    Diabetes Obes Metab; 2012 Dec; 14(12):1129-36. PubMed ID: 22830956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR; Gilbert RE; Yue DK
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: A real-world multicentre prospective study in 120 adults with type 1 diabetes.
    Schlüter S; Freckmann G; Heinemann L; Wintergerst P; Lange K
    Diabet Med; 2021 Feb; 38(2):e14467. PubMed ID: 33230860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.